ARTICLE | Company News
Agouron other research news
February 8, 1999 8:00 AM UTC
AGPH said that AG1549 exhibited potency in vitro against HIV-1 strains containing mutations conferring resistance to other NNRTIs. AG1549 is in Phase I/II trials. Data were presented at the Conference...